953PD - Final overall survival analysis of patients with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) treated with sorafenib in the phase 3 DECISION trial: An exploratory crossover adjustment analyses
| Autor: | Brose, M., Jarzab, B., Elisei, R., Giannetta, L., Bastholt, L., Fouchardiere, Cdela, Pacini, F., Paschke, R., Nutting, C., Shong, Y.K., Sherman, S., Smit, J., Chung, J., Meinhardt, G., Schlumberger, M., Kappeler, C. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi329-vi329 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|